miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Mitochondrial Dynamics

Background:

• Myocardial infarction (MI) is a major global cause of death.
• Ischemia-reperfusion injury significantly contributes to MI severity and cardiac dysfunction.
• MicroRNAs (miRNAs) play critical roles in regulating cardiac function and disease.

Purpose of the Study:

• To investigate the role of microRNA-499 (miR-499) in myocardial infarction and ischemia-reperfusion injury.
• To elucidate the molecular mechanisms by which miR-499 affects cardiomyocyte apoptosis and cardiac dysfunction.
• To identify potential therapeutic targets for MI based on miR-499 modulation.

Main Methods:

• Analysis of miR-499 levels in the context of myocardial infarction.
• Luciferase reporter assays to confirm direct targeting of calcineurin isoforms by miR-499.
• Western blotting and mitochondrial fractionation to assess protein levels and localization.
• Assessment of cardiomyocyte apoptosis and mitochondrial fission.
• Investigation of p53's role in regulating miR-499 expression.

Main Results:

• Modulation of miR-499 levels impacts apoptosis and severity of myocardial infarction and cardiac dysfunction.
• miR-499 directly targets both α- and β-isoforms of calcineurin.
• miR-499 inhibits cardiomyocyte apoptosis by suppressing calcineurin-mediated dephosphorylation of dynamin-related protein-1 (Drp1).
• This leads to decreased Drp1 accumulation in mitochondria and reduced mitochondrial fission.
• p53 was identified as a transcriptional repressor of miR-499 expression.

Conclusions:

• miR-499 plays a crucial role in regulating the mitochondrial fission machinery in cardiomyocytes.
• The miR-499/calcineurin/Drp1 pathway is a key determinant of cardiomyocyte apoptosis during ischemia-reperfusion.
• Modulating miR-499 levels presents a promising therapeutic avenue for treating myocardial infarction and related cardiac dysfunction.